针对完成主要治愈性癌症治疗后个体的个性化远程直播运动效果:多国超级伞形随机对照试验(LION-RCT)研究方案
LION-RCT是一项多国随机对照试验,计划纳入352例完成主要治愈性癌症治疗(含化疗)后12-52周内、至少筛选出一种目标副作用的个体,随机1:1分配至干预组或等待名单对照组。干预组接受12周远程直播监督运动(每周3次,基础模块每周2次加针对最困扰副作用的特定模块每周1次)。主要结局为健康相关生活质量(EORTC QLQ-C30汇总评分)和基于最困扰副作用的标准化症状评分,主要评估时间点为基线后12周。
要点
- LION-RCT纳入完成主要治愈性癌症治疗(含化疗)后12-52周内且至少一种目标副作用筛查阳性的个体。
- 干预组接受12周远程直播监督运动,每周3次,含基础模块每周2次和针对最困扰副作用的特定模块每周1次。
- 主要结局为健康相关生活质量和基于最困扰副作用的标准化症状评分,主要时间点为基线后12周。
关键数值与推荐
- 干预组接受12周监督运动方案,包括每周3次远程直播运动,每次包含基础模块(每周2次)和一个针对最困扰副作用的特定模块(每周1次)。
- 主要结局为健康相关生活质量(EORTC QLQ-C30汇总评分)和基于每位参与者最困扰副作用的标准化症状评分(身体疲劳:EORTC QLQ-FA12;情绪困扰:PHQ-ADS;身体功能:EORTC QLQ-C30改良身体功能量表;化疗诱导的周围神经病变:EORTC QLQ-CIPN20)。
- 评估时间点为基线后6、12(主要时间点)、18(仅等待名单对照组)、24和36周。
临床怎么用
- 若被证明(成本)有效,远程直播运动可作为标准癌症随访照护的一部分提供给个体,以扩大运动支持的可及范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exercise is an effective strategy to reduce cancer- and treatment-related side effects and improve quality of life (QoL). Larger exercise effects are observed in cancer survivors with a higher symptom burden and when exercise interventions are supervised. Most studies conducted to date have not screened for symptoms at baseline and tailored the exercise intervention accordingly. Additionally, time and travel distance are common barriers to participation in supervised in-person exercise programs. Live-remote exercise, where exercise sessions are supervised by an exercise professional via a videoconferencing platform, might help overcome these barriers. Here, we describe the design of the LION randomized controlled trial (RCT). This RCT aims to assess the (cost-)effectiveness of side effect-targeted, live-remote exercise on QoL and the participants' most burdensome side effect-fatigue, emotional distress, low physical functioning, or chemotherapy-induced peripheral neuropathy (CIPN)-in individuals who have completed primary curative cancer treatment. METHODS: The LION study is a multinational RCT that will enroll 352 individuals who have completed primary curative cancer treatment including chemotherapy, within the previous 12-52 weeks and screen positive for ≥ 1 of the targeted side effects. Participants are randomly allocated (1:1) to the intervention or wait list control group. Participants in the intervention group receive a 12-week supervised exercise program consisting of three live-remote exercise sessions per week. Each participant receives the same base module (2×/week) and one specific module (1×/week) targeting their most burdensome side effect. Wait list control participants receive the same exercise program 12 weeks post-baseline. The primary outcomes are HRQoL (EORTC QLQ-C30 summary score) and a standardized symptom score based on each participant's most burdensome side effect (physical fatigue: EORTC QLQ-FA12, emotional distress: PHQ-ADS, physical functioning: EORTC QLQ-C30 modified physical functioning scale, CIPN: EORTC QLQ-CIPN20), assessed at baseline, 6, 12 (primary time point), 18 (wait list control group only), 24 and 36 weeks post-baseline. DISCUSSION: This RCT will provide evidence regarding the (cost-)effectiveness of side effect-targeted, live-remote exercise in individuals experiencing side effects following primary curative cancer treatment. If proven (cost-)effective, live-remote exercise could be offered to individuals as part of standard follow-up cancer care to extend the reach of exercise support. TRIAL REGISTRATION: NCT06270628. Registered on February 13, 2024.
引用
- Hiensch AE, Müller J, Zopf EM, et al. Effects of personalized live-remote exercise for individuals living beyond primary curative cancer treatment: study protocol for a multinational, super umbrella randomized controlled trial (LION-RCT). Trials. 2025. PMID: 41287048. doi:10.1186/s13063-025-09263-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。